Breaking News Instant updates and real-time market news.

LOXO

Loxo Oncology

$83.23

2.05 (2.53%)

, BAYRY

Bayer

$31.78

-0.274 (-0.85%)

13:45
11/14/17
11/14
13:45
11/14/17
13:45

Loxo Oncology upgraded to Outperform from Market Perform at JMP Securities

JMP Securities analyst Michael King upgraded Loxo Oncology (LOXO) to Outperform from Market Perform and set a $95 price target on the stock after the company announced a global partnership with Bayer (BAYRY) to develop and commercialize larotrectinib and LOXO-195.

LOXO

Loxo Oncology

$83.23

2.05 (2.53%)

BAYRY

Bayer

$31.78

-0.274 (-0.85%)

  • 14

    Nov

  • 16

    Nov

  • 29

    Nov

LOXO Loxo Oncology
$83.23

2.05 (2.53%)

11/14/17
COWN
11/14/17
NO CHANGE
COWN
Outperform
Loxo agreement in best interest of shareholders, says Cowen
Cowen analyst Eric Schmidt says that while Loxo Oncology's (LOXO) collaboration with Bayer (BAYRY) "will turn a few heads" since it includes 50% of U.S. rights, it represents a "solid monetization" of the company's TRK inhibitor franchise. Further, the analyst notes optimism before the agreement that Loxo might be an acquisition candidate ahead of larotrectinib's 2018 launch could be contributing to today's selloff. The deal is in the best interests of shareholders and $1B in nearer-term payments is substantial, Schmidt contends. He believes the agreement can be seen as one that monetizes a good portion of the TRK franchise value for upfront cash. The analyst keeps an Outperform rating on Loxo Oncology. The stock in early trading is down 5% to $79.11.
10/20/17
SBSH
10/20/17
NO CHANGE
Target $112
SBSH
Buy
Loxo Oncology price target raised to $112 from $86 at Citi
Citi analyst Yigal Nochomovitz raised his price target for Loxo Oncology to $112 citing a more bullish stance on LOXO-292. The RET Inhibitor will emerge with "similar highly promising efficacy/duration" data as the Phase 1 data mature, with substantial similarity to larotrectinib's overall data path, Nochomovitz tells investors in a research note. The analyst now models probability adjusted U.S. peak sales of $540M. He reiterates a Buy rating on Loxo.
09/29/17
BTIG
09/29/17
NO CHANGE
BTIG
Loxo Oncology price target raised to $102 from $75 at BTIG
BTIG analyst Dane Leone raised his price target on Loxo after the company reported data on its LOXO-292 drug. The analyst says that the results were positive, leading him to include revenue from the drug in his model for the company. He says that the data "provides compelling evidence of clinical activity," and he keeps a Buy rating on the shares.
08/29/17
08/29/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JA Solar (JASO) downgraded to Sell from Hold at Axiom with analyst Gordon Johnson saying recent results suggest that Chinese module vendors are not benefiting significantly from any U.S. demand pull-in. 2. Finish Line (FINL) was downgraded to Sell from Neutral at Citi and Deutsche Bank, while being downgraded to Underperform from Neutral at Buckingham, and to Neutral from Buy at FBR Capital. 3. Intellia Therapeutics (NTLA) downgraded to Neutral from Buy at Chardan with analyst Madhu Kumar citing relative valuation. 4. Loxo Oncology (LOXO) downgraded to Market Perform from Outperform at JMP Securities with analyst Michael King saying he believes the company's platform and assets under development are now being fairly valued with the stock having risen above his $71 price target. 5. Cemex (CX) downgraded to Neutral from Buy at BofA/Merrill with analyst Carlos Peyrelongue citing lack of positive catalysts and risk of disappointment in Mexico and the U.S. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BAYRY Bayer
$31.78

-0.274 (-0.85%)

10/17/17
NEED
10/17/17
NO CHANGE
Target $33
NEED
Buy
Exelixis price target raised to $33 from $30 at Needham
Needham analyst Chad Messer raised his price target on Exelixis (EXEL) to $33, noting the latest trial data for advanced renal cell carcinoma treatment, Cabozantinib, positions it for near and long term growth. Messer says the results may be sufficient to allay competitive concerns from the recently approved Bayer (BAYRY) Stivarga, as cabozantinib offers a potentially more attractive efficacy profile.
10/16/17
RHCO
10/16/17
NO CHANGE
Target $35
RHCO
Buy
Cabo result better positions Exelixis as acquisition target, says SunTrust
SunTrust analyst Peter Lawson raised his price target on Exelixis (EXEL) to $35 from $33 and maintained his Buy rating, saying the latest CELESTIAL trial cabozantinib positions the treatment well against its main competitor - Bayer's (BAYRY) Regorafenib. Lawson adds that the trial result validates the expansion of cabozantinib beyond kidney cancer and better positions Exelixis as a potentially attractive M&A target.
10/16/17
JEFF
10/16/17
NO CHANGE
Target $115
JEFF
Buy
Jefferies ups price target on top global pick AbbVie to $115
Jefferies analyst Jeffrey Holford keeps AbbVie (ABBV) as his top global Pharmaceuticals pick for October, followed by Roche (RHHBY), Novartis (NVS), Bayer (BAYRY), Johnson & Johnson (JNJ), Eli Lilly (LLY) and GlaxoSmithKline (GSK). The analyst raised his price target for AbbVie shares to $115 from $107 and keeps a Buy rating on the name. Among his other target changes include bumping Eli Lilly's to $100 from $96.

TODAY'S FREE FLY STORIES

HPQ

HP Inc.

$22.47

0.355 (1.61%)

17:47
11/21/17
11/21
17:47
11/21/17
17:47
Hot Stocks
HP Inc.: 'Stay tuned' for news on metal 3D printing »

Says plans to introduce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

THC

Tenet

$13.34

0.17 (1.29%)

17:47
11/21/17
11/21
17:47
11/21/17
17:47
Initiation
Tenet initiated  »

Tenet initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPNT

LifePoint

$43.85

0.65 (1.50%)

17:47
11/21/17
11/21
17:47
11/21/17
17:47
Initiation
LifePoint initiated  »

LifePoint initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LHCG

LHC Group

$67.98

1.46 (2.19%)

17:46
11/21/17
11/21
17:46
11/21/17
17:46
Initiation
LHC Group initiated  »

LHC Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

HLS

HealthSouth

$48.46

0.85 (1.79%)

17:46
11/21/17
11/21
17:46
11/21/17
17:46
Initiation
HealthSouth initiated  »

HealthSouth initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCA

HCA Healthcare

$75.89

1.28 (1.72%)

17:46
11/21/17
11/21
17:46
11/21/17
17:46
Initiation
HCA Healthcare initiated  »

HCA Healthcare initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

AMED

Amedisys

$54.97

2.29 (4.35%)

17:45
11/21/17
11/21
17:45
11/21/17
17:45
Initiation
Amedisys initiated  »

Amedisys initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$22.46

0.34 (1.54%)

17:45
11/21/17
11/21
17:45
11/21/17
17:45
Hot Stocks
HP Inc. sees printing segment continuing to make 'significant' progress »

Comments taken from Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

17:45
11/21/17
11/21
17:45
11/21/17
17:45
General news
Breaking General news story  »

Federal Reserve Chair…

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

, AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

17:38
11/21/17
11/21
17:38
11/21/17
17:38
Periodicals
Nippon made all-cash offer to buy Axalta Coating, Reuters reports »

Japan's Nippon Paint…

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIVO

TiVo

$17.65

0.15 (0.86%)

, CMCSA

Comcast

$36.42

0.59 (1.65%)

17:34
11/21/17
11/21
17:34
11/21/17
17:34
Hot Stocks
TiVo wins ITC patent lawsuit against Comcast »

TiVo (TIVO) has won its…

TIVO

TiVo

$17.65

0.15 (0.86%)

CMCSA

Comcast

$36.42

0.59 (1.65%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$16.73

0.29 (1.76%)

, AXTA

Axalta Coating

$33.87

0.33 (0.98%)

17:27
11/21/17
11/21
17:27
11/21/17
17:27
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

GME

GameStop

$16.73

0.29 (1.76%)

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

EXEL

Exelixis

$26.05

0.4 (1.56%)

GES

Guess

$17.95

0.17 (0.96%)

CAL

Caleres

$30.99

0.05 (0.16%)

HPQ

HP Inc.

$22.46

0.34 (1.54%)

CRM

Salesforce

$108.80

1.43 (1.33%)

HPE

HP Enterprise

$14.12

0.03 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 27

    Nov

  • 28

    Nov

  • 11

    Dec

SSY

SunLink Health Systems

$1.52

0.03 (2.01%)

17:27
11/21/17
11/21
17:27
11/21/17
17:27
Hot Stocks
SunLink Health Systems commences tender offer to repurchase 1.56M shares »

SunLink Health Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYHT

Shineco

$3.26

-0.27 (-7.65%)

17:26
11/21/17
11/21
17:26
11/21/17
17:26
Syndicate
Breaking Syndicate news story on Shineco »

Shineco files $25M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMNI

Rimini Street

$7.54

0.0842 (1.13%)

17:22
11/21/17
11/21
17:22
11/21/17
17:22
Syndicate
Rimini Street files to sell 22.11M shares of common stock for holders »

Also files to sell 6.06M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$108.80

1.43 (1.33%)

17:20
11/21/17
11/21
17:20
11/21/17
17:20
Earnings
Breaking Earnings news story on Salesforce »

Salesforce says sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

GME

GameStop

$16.74

0.31 (1.89%)

17:18
11/21/17
11/21
17:18
11/21/17
17:18
Hot Stocks
GameStop 'on track' to achieve FY17 collectibles revenue view »

Says "on track"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

GME

GameStop

$16.73

0.29 (1.76%)

, NTDOY

Nintendo

$49.83

-0.228 (-0.46%)

17:16
11/21/17
11/21
17:16
11/21/17
17:16
Hot Stocks
GameStop: Xbox One X has already had 'strong start' »

GameStop (GME) says it…

GME

GameStop

$16.73

0.29 (1.76%)

NTDOY

Nintendo

$49.83

-0.228 (-0.46%)

MSFT

Microsoft

$83.72

1.19 (1.44%)

ATVI

Activision Blizzard

$64.50

0.57 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CRM

Salesforce

$108.80

1.43 (1.33%)

, AMZN

Amazon.com

$1,139.49

13.18 (1.17%)

17:14
11/21/17
11/21
17:14
11/21/17
17:14
Hot Stocks
Salesforce: Amazon.com continues to be key partner in International expansion »

Says International…

CRM

Salesforce

$108.80

1.43 (1.33%)

AMZN

Amazon.com

$1,139.49

13.18 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

  • 18

    Mar

ALGT

Allegiant Travel

$138.40

0.85 (0.62%)

17:14
11/21/17
11/21
17:14
11/21/17
17:14
Hot Stocks
Allegiant Travel reaches tentative agreement with TWU »

Allegiant announces that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$16.73

0.29 (1.76%)

, NTDOY

Nintendo

$49.83

-0.228 (-0.46%)

17:12
11/21/17
11/21
17:12
11/21/17
17:12
Hot Stocks
GameStop: Q4 hardware sales to be driven by Switch, Xbox One X »

GameStop (GME) says Q4…

GME

GameStop

$16.73

0.29 (1.76%)

NTDOY

Nintendo

$49.83

-0.228 (-0.46%)

MSFT

Microsoft

$83.72

1.19 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

JE

Just Energy

$4.43

-0.05 (-1.12%)

17:10
11/21/17
11/21
17:10
11/21/17
17:10
Hot Stocks
Just Energy launches operations in Japan »

Just Energy Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$49.38

0.27 (0.55%)

, OZM

Och-Ziff Capital

$3.11

-0.01 (-0.32%)

17:10
11/21/17
11/21
17:10
11/21/17
17:10
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley, Och-Ziff Capital »

Morgan Stanley reports 5%…

MS

Morgan Stanley

$49.38

0.27 (0.55%)

OZM

Och-Ziff Capital

$3.11

-0.01 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$16.73

0.29 (1.76%)

, NTDOY

Nintendo

$49.83

-0.228 (-0.46%)

17:09
11/21/17
11/21
17:09
11/21/17
17:09
Hot Stocks
GameStop: Q3 results driven by strong Switch demand, fall software lineup »

GameStop (GME) says…

GME

GameStop

$16.73

0.29 (1.76%)

NTDOY

Nintendo

$49.83

-0.228 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CLS

Celestica

$10.67

-0.09 (-0.84%)

17:04
11/21/17
11/21
17:04
11/21/17
17:04
Hot Stocks
Celestica expands operations in Oradea, Romania »

Celestica Inc announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.